Overactivity of the brain renin-angiotensin system (RAS) has been implicated in the development and maintenance of hypertension in several experimental animal models. We have recently reported that, in the murine brain RAS, angiotensin II (AngII) is converted by aminopeptidase A (APA) into angiotensin III (AngIII), which is itself degraded by aminopeptidase N (APN), both peptides being equipotent to increase vasopressin release and arterial blood pressure when injected by the intracerebroventricular (i.c.v.) route. Because AngII is converted in vivo into AngIII, the exact nature of the active peptide is not precisely known. To delineate their respective roles in the central control of cardiovascular functions, specific and selective APA and APN inhibitors are needed to block the metabolic pathways of AngII and AngIII respectively. In the absence of such compounds for APA, we first explored the organization of the APA active site by site-directed mutagenesis. This led us to propose a molecular mechanism of action for APA similar to that proposed for the bacterial enzyme thermolysin deduced from X-ray diffraction studies. Secondly, we developed a specific and selective APA inhibitor, compound EC33 [(S)-3-amino-4-mercaptobutylsulphonic acid], as well as a potent and selective APN inhibitor, PC18 (2-amino-4-methylsulphonylbutane thiol). With these new tools we examined the respective roles of AngII and AngIII in the central control of arterial blood pressure. A central blockade of APA with the APA inhibitor EC33 suppressed the pressor effect of exogenous AngII, suggesting that brain AngII must be converted into AngIII to increase arterial blood pressure. Furthermore, EC33, injected alone i.c.v. but not intravenously, caused a dose-dependent decrease in arterial blood pressure by blocking the formation of brain AngIII but not systemic AngIII. This is corroborated by the fact that the selective APN inhibitor PC 18 administered alone via the i.c.v. route increased arterial blood pressure. This pressor response was blocked by prior treatment with the angiotensin type 1 receptor antagonist losartan, showing that blocking the action of APN on AngIII metabolism leads to an increase in endogenous AngIII levels, resulting in arterial blood pressure increase through an interaction with angiotensin type 1 receptors. These results demonstrate that AngIII is a major effector peptide of the brain RAS, exerting a tonic stimulatory control over arterial blood pressure. Thus APA, the enzyme responsible for the formation of brain AngIII, represents a potential central therapeutic target that justifies the development of APA inhibitors, crossing the blood-brain barrier, as central anti-hypertensive agents.
Skip Nav Destination
Close
Article navigation
August 2000
- Cover Image
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkAdvertising
Conference Article|
August 01 2000
Aminopeptidase A, which generates one of the main effector peptides of the brain renin-angiotensin system, angiotensin III, has a key role in central control of arterial blood pressure
A. Reaux;
A. Reaux
*INSERM U 36, College de France, 3 rue d'Ulm, 75005 Paris, France
Search for other works by this author on:
X. Iturrioz;
X. Iturrioz
*INSERM U 36, College de France, 3 rue d'Ulm, 75005 Paris, France
Search for other works by this author on:
G. Vazeux;
G. Vazeux
*INSERM U 36, College de France, 3 rue d'Ulm, 75005 Paris, France
Search for other works by this author on:
M.-C. Fournie-Zaluski;
M.-C. Fournie-Zaluski
†INSERM U 266, CNRS UMR 8600, 4 avenue de l'Observatoire, 75270 Paris Cedex 06, France
Search for other works by this author on:
C. David;
C. David
†INSERM U 266, CNRS UMR 8600, 4 avenue de l'Observatoire, 75270 Paris Cedex 06, France
Search for other works by this author on:
B. P. Roques;
B. P. Roques
†INSERM U 266, CNRS UMR 8600, 4 avenue de l'Observatoire, 75270 Paris Cedex 06, France
Search for other works by this author on:
P. Corvol;
P. Corvol
*INSERM U 36, College de France, 3 rue d'Ulm, 75005 Paris, France
Search for other works by this author on:
C. Llorens-Cortes
C. Llorens-Cortes
1
*INSERM U 36, College de France, 3 rue d'Ulm, 75005 Paris, France
1To whom correspondence should be addressed (e-mail c.llorens-cortes@college-de-france.fr)
Search for other works by this author on:
Biochem Soc Trans (2000) 28 (4): 435–440.
Article history
Received:
March 01 2000
Citation
A. Reaux, X. Iturrioz, G. Vazeux, M.-C. Fournie-Zaluski, C. David, B. P. Roques, P. Corvol, C. Llorens-Cortes; Aminopeptidase A, which generates one of the main effector peptides of the brain renin-angiotensin system, angiotensin III, has a key role in central control of arterial blood pressure. Biochem Soc Trans 1 August 2000; 28 (4): 435–440. doi: https://doi.org/10.1042/bst0280435
Download citation file:
Close
Sign in
Don't already have an account? Register
Sign in to your personal account
You could not be signed in. Please check your email address / username and password and try again.
Biochemical Society Member Sign in
Sign InSign in via your Institution
Sign in via your InstitutionGet Access To This Article
12
Views
0
Citations